Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Vitamin D for Hyperparathyroidism in Postmenopausal Osteoporosis
NCT05347082Completed
- Sponsor
- Hospital Regional 1° de Octubre
- Start
- Apr 2021
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Open-label, single-arm trial of vitamin d in postmenopausal osteoporosis, hyperparathyroidism and vitamin D deficiency, sponsored by Hospital Regional 1° de Octubre. Primary endpoints: Number of Participants with Remission of Hyperparathyroidism at 4 weeks, Number of Participants with Remission of Hypovitaminosis D at 4 weeks and 2 more. Started Apr 2021; status: completed.
02
Drugs
vitamin d
03
Conditions
postmenopausal osteoporosishyperparathyroidismvitamin D deficiency
Beyond the preview
Go deeper on NCT05347082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05347082.